{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:45:19Z","timestamp":1761252319827,"version":"3.33.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1136\/ard.60.4.385","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"385-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis"],"prefix":"10.1016","volume":"60","author":[{"given":"P","family":"Lamprecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Moosig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Herlyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Csernok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W L","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.60.4.385_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international conference.","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.4.385_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002281-199701000-00006","article-title":"The spectrum and treatment of virus-associated vasculitides.","volume":"9","author":"Guillevin","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases.","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1136\/ard.60.4.385_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/ard.57.12.701","article-title":"Mixed cryoglobulinemia after hepatits C virus: more or less ambiguity.","volume":"57","author":"Agnello","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.4.385_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","article-title":"Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis.","volume":"54","author":"D'Amico","year":"1998","journal-title":"Kidney Int"},{"key":"10.1136\/ard.60.4.385_bib6","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","article-title":"Cryoglobulinemic vasculitis.","volume":"42","author":"Lamprecht","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.4.385_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002281-200001000-00009","article-title":"Relation between infection and autoimmunity in mixed cryoglobulinemia.","volume":"12","author":"Ferri","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/030006059602400302","article-title":"Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.","volume":"24","author":"Simsek","year":"1996","journal-title":"J Int Med Res"},{"key":"10.1136\/ard.60.4.385_bib9","first-page":"575","article-title":"Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis.","volume":"43","author":"Yang","year":"1996","journal-title":"Hepato-Gastroenterol"},{"key":"10.1136\/ard.60.4.385_bib10","first-page":"319","article-title":"Birmingham vasculitis activity score, disease extent index and complement C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis.","volume":"18","author":"Lamprecht","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00920793","article-title":"Disease severity in rheumatoid arthritis: relationship of plasma tumor necrosis factor-\u03b1, soluble interleukin 2-receptor, soluble CD4\/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures.","volume":"12","author":"Beckham","year":"1992","journal-title":"J Clin Immunol"},{"key":"10.1136\/ard.60.4.385_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/1529-0131(199803)41:3<445::AID-ART10>3.0.CO;2-3","article-title":"Churg-Strauss syndrome. Serum markers of lymphocyte activation and endothelial damage.","volume":"41","author":"Schmitt","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.4.385_bib13","first-page":"S187","article-title":"GISC protocol experience in the treatment of essential mixed cryoglobulinemia.","volume":"13 (suppl 13)","author":"Piotelli","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib14","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease.","volume":"88","author":"Monti","year":"1995","journal-title":"Q J Med"},{"key":"10.1136\/ard.60.4.385_bib15","first-page":"643","article-title":"Cryoglobulinemia in chronic hepatitis C infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryopreciptates.","volume":"33","author":"Hartmann","year":"1995","journal-title":"Z Gastroenterol"},{"key":"10.1136\/ard.60.4.385_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9343(97)00049-1","article-title":"High levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.","volume":"102","author":"Wang","year":"1997","journal-title":"Am J Med"},{"key":"10.1136\/ard.60.4.385_bib17","first-page":"671","article-title":"Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis.","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"10.1136\/ard.60.4.385_bib18","first-page":"275","article-title":"Vital assessment of vasculitis.","volume":"13","author":"Bacon","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib19","first-page":"777","article-title":"Wegener's granulomatosis. Anatomic correlates, a proposed classification.","volume":"51","author":"DeRemee","year":"1976","journal-title":"Mayo Clin Proc"},{"key":"10.1136\/ard.60.4.385_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/art.1780370622","article-title":"Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis.","volume":"37","author":"Reinhold-Keller","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.4.385_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1191\/096120398678920118","article-title":"Wegener's granulomatosis: disease course, assessment of activity and extent and treatment.","volume":"7","author":"deGroot","year":"1998","journal-title":"Lupus"},{"key":"10.1136\/ard.60.4.385_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis.","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1136\/ard.60.4.385_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03259318","article-title":"Mixed cryoglobulinemia. A guide to drug treatment.","volume":"5","author":"Misiani","year":"1996","journal-title":"Clinical Immunotherapy"},{"key":"10.1136\/ard.60.4.385_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0950-3579(97)80046-5","article-title":"Systemic necrotizing vasculitis.","volume":"11","author":"Gross","year":"1997","journal-title":"Bailli\u00e8re's Clin Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(97)80281-4","article-title":"Interferon-\u03b1 treatment of hepatitis C virus-associated cryoglobulinemia.","volume":"27","author":"Polzien","year":"1997","journal-title":"J Hepatol"},{"key":"10.1136\/ard.60.4.385_bib26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-125-8-199610150-00006","article-title":"Hepatitic C.","volume":"125","author":"Sharara","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.60.4.385_bib27","first-page":"S175","article-title":"Interferon in the treatment of mixed cryoglobulinemia.","volume":"13(suppl 13)","author":"Migliaresi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-\u03b1 in mixed cryoglobulinemia patients. A randomized, crossover-controlled trial.","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1136\/ard.60.4.385_bib29","first-page":"77","article-title":"Serum complement pattern in essential mixed cryoglobulinemia.","volume":"32","author":"Tarantino","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.60.4.385_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/1523-1747.ep12543575","article-title":"A newly described control mechanism of complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement).","volume":"74","author":"Haydey","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard.60.4.385_bib31","first-page":"65","article-title":"Immune complexes and complement profile in essential mixed cryoglobulinemia before and after plasma exchange.","volume":"6","author":"Corvetta","year":"1983","journal-title":"Int J Artif Organs"},{"key":"10.1136\/ard.60.4.385_bib32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780350914","article-title":"Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis.","volume":"35","author":"Schmitt","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.4.385_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF00180543","article-title":"Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus.","volume":"72","author":"Mrowka","year":"1994","journal-title":"Clin Invest"},{"key":"10.1136\/ard.60.4.385_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2249.1997.4281327.x","article-title":"Naive and memory T cells infiltrates in chronic hepatits C: phenotypic changes with interferon treatment.","volume":"109","author":"Imada","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.60.4.385_bib35","first-page":"84","article-title":"Hohe Serumspiegel von ICAM-1 bei der aktiven Wegener'schen Granulomatose.","volume":"20","author":"Hauschild","year":"1992","journal-title":"Immun Infekt"},{"key":"10.1136\/ard.60.4.385_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002281-199701000-00004","article-title":"Cell adhesion molecules in vasculitis.","volume":"9","author":"Cohen Tervaert","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0167-5699(97)84661-0","article-title":"Hodgkin's disease: a tumor with disturbed immunological pathways.","volume":"18","author":"Gruss","year":"1997","journal-title":"Immunol Today"},{"key":"10.1136\/ard.60.4.385_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2249.1996.915607.x","article-title":"Serum levels of soluble CD30 in chronic hepatitis B virus infection.","volume":"103","author":"Fattovich","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.60.4.385_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2249.1997.d01-1005.x","article-title":"High serum level of soluble CD30 in acute primary HIV-1 infection.","volume":"108","author":"Pizollo","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.60.4.385_bib40","first-page":"339","article-title":"Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity.","volume":"13","author":"Caligaris-Cappio","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.60.4.385_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2249.1997.d01-991.x","article-title":"Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease.","volume":"108","author":"Giacomelli","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.60.4.385_bib42","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1182\/blood.V77.9.1983.1983","article-title":"Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.","volume":"77","author":"Gause","year":"1991","journal-title":"Blood"},{"key":"10.1136\/ard.60.4.385_bib43","first-page":"6","article-title":"Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon-alfa.","volume":"24","author":"Cacciarelli","year":"1996","journal-title":"Hepatology"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724442982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724442982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.60.4.385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:35:15Z","timestamp":1737264915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724442982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0003496724442982"],"URL":"https:\/\/doi.org\/10.1136\/ard.60.4.385","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2001,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.60.4.385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Annals of the Rheumatic Diseases. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}